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Aim: The purpose of this evaluation was to obtain views from general practitioners
(GPs) who piloted the electronic risk assessment tools (eRATs) for suspected lung or
colorectal cancer. We wanted to ﬁnd out whether GPs were able to integrate these tools
into their everyday practice. We were also keen to identify facilitators and barriers to
their more widespread use. Background: Cancer remains one of UK’s biggest health
problems, in terms of morbidity and mortality. Comparative European data show that
ﬁve-year survival ﬁgures for many cancers are lower in the United Kingdom than in
comparable European countries. eRATs are intended to aid recognition of symptoms of
lung and colorectal cancers in patients aged 40 years and over. Methods: This was a
qualitative study; telephone interviews were conducted with 23 GPs who piloted the
eRATs. A systematic qualitative analysis was applied to the data. The normalisation
process model was used after data collection. This theory-driven conceptual framework
was used to examine the operationalisation of this intervention in Primary Care.
Findings: Electronic decision-support tools appear to be useful additions to the
resources available to GPs in order to assist them with recognizing potential cancer
symptoms. However, the tools need to be reﬁned in order to integrate them into GP
practice. The tools raised GPs’ awareness about cancer because of the prompt facility of
the software, although this also raised the potential of ‘prompt fatigue’. GPs constantly
receive alerts via their clinical system, particularly related to the Quality and Outcomes
Framework. The integration of eRATs into routine practice could be engendered by
improvement to the training packages that accompany them, and by its delivery via a
platform compatible with all GP clinical systems.
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Introduction
In terms of morbidity and mortality, cancer
remains one of UK’s biggest health problems. This
has led to increased interest in how patients and
professionals recognize cancer symptoms. This
is particularly because European data show that
one-year survival ﬁgures for many cancers are
poorer in the United Kingdom than in comparable
European countries (Verdecchia et al., 2007;
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Coleman et al., 2011). This suggests that people in
the United Kingdom may be diagnosed at a later
point in their cancer history than others in Europe,
leading to the question as to why there should be
this apparent delay in diagnosis. Although there
may be a number of explanations for this, the
prevalent view is that the pathway from ﬁrst
symptom to diagnosis might be partly responsible
(Richards, 2009). In the UK healthcare system,
this pathway involves primary care, and most
commonly general practitioners (GPs). Owing to
their traditional gate-keeping role within the UK
healthcare system, there is an emerging body of
work on the role of GPs in the process to cancer
diagnosis (Richards, 2009; Hippisley‐Cox and
Coupland, 2011; Mansell et al., 2011; Hamilton
et al., 2013; Mitchell et al., 2013).
There is agreement that cancer diagnosis in pri-
mary care is complex and attempts have been
made to understand (Hamilton, 2009), and impact
upon this process (Mansell et al., 2011). Research
has been carried out to comprehend in greater
detail the symptoms that cancer patients present
within primary care, and from these analyses to
develop algorithms to assist GPs in assessing
patients with potential cancer symptoms.
This resulted in desk-based risk assessment tools
(RATs): decision-support tools for GPs that are
intended to aid recognition of potential cancer
symptoms. These tools have arisen from the Can-
cer Prediction in Exeter studies, and have been
developed to quantify the risk of cancer in symp-
tomatic primary-care patients (Hamilton et al.,
2005a, 2005b; Hamilton, 2009). The RATs were
supplied in several formats including mousemats
and ﬂipcharts. The evaluation of these desk-based
tools (for lung and colorectal cancer) showed that
they appeared to help GPs in their selection of
patients for cancer investigation by helping them
conﬁrm a need for investigation as well as allowing
reassurance when investigation was not needed
(Hamilton et al., 2013; Green et al., 2014). They
were seen as particularly helpful in assisting GPs
with cases of unusual presentations, and GPs also
reported making different referral decisions as a
result of using the RATs than those they might
otherwise have made. Many GPs expressed a
preference for electronic tools fully integrated into
clinical systems to reﬂect the ways in which GPs
work. We have reported these ﬁndings separately
(Hamilton et al., 2013; Green et al., 2014).
Subsequent to the desk-based study, Macmillan
Cancer Support developed an electronic version –
the electronic risk assessment tools (eRATs). This
paper is a qualitative evaluation of the eRATs pilot.
Methods
The eRATs utilised software from the Informatica
Clinical Audit Platform (iCAP), a software
programme that some general practices use in
addition to their clinical package. The iCAP is
compatible with the various clinical packages used
by practices (e.g., EMIS, VISION). The following
three eRATs were piloted: the eRAT for lung
cancer (non-smokers), the eRAT for lung cancer
(smokers) and the eRAT for colorectal cancer.
Each consists of three components as follows:
(1) in-consultation on-screen prompts; (2) an
interactive risk calculator and (3) audit tables of
patients with calculated positive predictive values
(PPVs).
In total, 53 practices were recruited to pilot these
tools: 38 practices from Wales, six from Scotland
and nine from England. All practices were invited
by the research team to participate in an interview
in order to evaluate users’ experiences of the three
eRATs. The focus of the qualitative evaluation
was on the applicability, usability and the process
of implementation of the three eRATs in primary
care. A total of 23 GPs accepted our invitation;
more men (n = 13) than women (n = 10) GPs
participated in the study. Purposive sampling was
not possible because participants in the evaluation
study were self-selecting. Nevertheless, partici-
pants in the interview served a diversity of prac-
tices located in deprived to afﬂuent areas.
We determined that telephone interviews would
be the most efﬁcient way of data collection, based
on the previous study we had conducted (Hamilton
et al., 2013; Green et al., 2014).We agree with others
that this interview method can be a preferred
option to face-to-face interviews (Sturges and
Hanrahan, 2004; Novick, 2008). The interviews
were conducted between February and May 2012
by L.D. and T.G. The software had been installed
for a minimum of six months before the interview.
A topic guide was speciﬁcally designed for the
telephone interviews. We reiterate that the aim of
this evaluation was to collect data on the (non)use
of the tools and on the experiences of using the
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tool in everyday practice. The interview schedule
focussed on the following topics:
∙ implementation and training;
∙ practical experience of using the eRATs;
∙ use of eRATs with patients in consultation;
∙ changes to practice inﬂuenced by the eRATs;
∙ positive and negative aspects of the electronic
tools;
∙ inﬂuence on referral thresholds;
∙ use of the different components of each tool;
∙ general perception on the integration of eRATs
in routine practice.
The analysis was guided by the following
research question: Which factors facilitated or
hindered the implementation and the use of these
tools? During the analysis, regular meetings were
held by the research team to discuss the emergent
themes from the ﬁeldwork material. To ensure a
transparent and in-depth coding process, we
applied a systematic approach to the analysis of
the data. This included a ﬁrst phase in which L.D.
and T.G. performed a repeated close reading of
each interview transcript in order to develop a
detailed index of the key themes emerging from
the data (Pope et al., 2000). This led to a coding
framework with descriptive code categories. This
was followed by the second coding phase in which
memoing and focussed coding led to translating
the descriptive codes into analytical codes – that is,
more abstract code categories (Hesse-Biber,
2007). This process led to our decision to map our
ﬁndings to the normalisation process model
(NPM), a theory-driven conceptual framework
that assists in explaining the process by which
interventions become routinely embedded in
healthcare practice (May et al., 2007a, 2007b).
Following Wilkes and Rubin (2009), who also ret-
rospectively applied the NPM, we ﬁrst provide a
summary of the NPM as applied to this evaluation
study before applying the results of our analysis to
the four constructs in the model.
NPM as applied to the eRATs evaluation
We conceptualized the implementation of the
eRATs in primary care as ‘complex interventions’,
because these are interventions built up from
several components that can act independently as
well as inter-dependently (Campbell et al., 2000).
The eRATs incorporated three components and
introduced new tasks to the GPs who used them.
These tasks not only included actions by the GP
but also interactions between GPs and other
practice staff. They consisted of multiple beha-
vioural, technological and organisational ele-
ments. Qualitative evaluations of complex
interventions are difﬁcult because of the multi-
faceted problems such an assessment poses (May,
2006), but theory-driven conceptual frameworks
can facilitate the data analysis. The NPM is such a
framework (May et al., 2007a, 2007b). It is recog-
nized for its ﬂexibility in application and can be
used at different stages in a qualitative study
(Wilkes and Rubin, 2009; MacFarlane and
O’Reilly-de Brún, 2012). Moreover, the NPM is a
robust conceptual model of implementation
and integration processes around new health
technologies and complex interventions (May,
2006; May et al., 2007a, 2007b). Its aim is to explain
factors promoting or inhibiting smooth imple-
mentation of complex interventions and how these
might become routinely embedded – that is, nor-
malised – in healthcare practice. The four compo-
nents, or ‘constructs’, of the NPM each reﬂect a
quality of the complex intervention: (1) interac-
tional workability; (2) relational integration;
(3) skill-set workability; and (4) contextual inte-
gration. We have applied this to our evaluation of
the eRATs (see Figure 1). In what follows, we
demonstrate how our ﬁndings ﬁtted into these four
constructs.
Interactional workability
Key themes: integration into GPs’ computer
systems; facilitators and barriers in the use of the
tools; and inﬂuence on referral behaviour.
We received a range of conﬂicting responses
with respect to how well the eRATs ﬁtted into
current practice. For example, the tools sat within
an electronic system separate from the clinical
system, which necessitated additional log-on. This
was reported as a barrier by some users. An addi-
tional factor in the GPs’ perception of the eRATs’
compatibility with their clinical systems was whe-
ther iCAP or Audit + (which runs on top of the
iCAP) was new to them, which was the case for
approximately half of our respondents:
‘I think this issue of the computer resources is
important. It’s got to be something that
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becomes a regular part of your practice,
really. So from that point of view, certainly
the IT people ought to sort that side of
things out’.
(GP/10)
GPs used the three components of the eRATS
to varying degrees, for example, how they reacted
to the on-screen prompts was inﬂuenced by dif-
ferent factors: the approach of the doctor; the GP’s
clinical experience; and time pressures in speciﬁc
consultations. An important ﬁnding was, however,
the danger of prompt overload. The vast majority
of interviewees asserted that they experienced
information overload, as pop-ups frequently
ﬂash on their computer screens. This could lead, as
one GP commented, to ‘prompt fatigue’. It is,
therefore, crucial that the threshold levels of all
prompts are valid:
‘There are somany things on it, so many things
popping up, so many things prompting you.
You don’t probably respond to all the prompts,
because there’s a box here, a box there, a box
everywhere, and you don’t see everything (…)
It’s such a busy screen you don’t respond to
everything and this doesn’t pop up’.
(GP/3)
The second component, the interactive risk cal-
culator, appeared to be used less frequently than
the other two components, which might be related
to the limited access to training in the use of the
tools, resulting in a lack of awareness of all the
tools’ functions. Some respondents indicated that
they looked at the PPV tables, but only a minority
actively reviewed these to consider patients who
appeared to be at high risk.
The most signiﬁcant function of the eRATs,
ﬂagged up by the vast majority of GPs, was that the
tools raised their awareness of potential cancer
symptoms and both reminded and alerted them to
possible risks. Some GPs indicated that, although
the eRATs might not have greatly inﬂuenced their
referral rates, use of the tools meant that they
reﬂected more often on symptom presentations or
looked back at patients’ records:
‘Yes, I mean, I suppose a lot of us as GPs we
do feel we’ve got a bit of a nose for a pro-
blem, you know, and what we want it … you
know, I don’t send everybody with these
symptoms up but I’m sending this one up
because I’ve just got this gut feeling that this
doesn’t feel right, you know. And you want
that respect in a sense. And it might not ﬁt in
with your grid of symptoms [laughs]’.
(GP/23)
To summarise, GPs reported that the eRATs
affected their referral thresholds to varying
degrees, and, in turn, their decision-making; they
were perceived as ‘back up’ tools that legitimised
their referral decisions.
Relational integration
Key themes: GPs’ understanding of the eRATs;





Congruence: What were GPs’ views on how the eRATs were integrated in
to their computer systems? In what ways did the GPs use the eRATs?
Were any particular problems or challenges posed? 
Disposal: Was the intended function of the eRATs met (i.e. flagging up risk
scores for suspected cancer)? Did GPs feel that the tools aided them in
decision making for referrals? 
Confidence: Did GPs understand and trust the tools?
Accountability: How did the eRATs relate to users’ existing knowledge and
initiative to reduce primary care delay in symptom recognition and referral?
How did GPs perceive their use of the tools would impact on secondary
care?
EXOGENOUS (Organisational ) FACTORS
Skill-set workability
Allocation: Who used the eRATs? Who needs to do what to stream line
these new decision-support tools in to routine practice?
Performance: What training should be offered to users? Are these
implementation tasks compatible with existing workload and skills?
Contextual integration
Execution: How do eRATs fit in primary care? What is the effect on GP-
patient relationships?
Realisation: What are the risks of GPs’ use of the tools?
Figure 1 The Normalisation Process Model as applied
to this evaluation of electronic risk assessment tools
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An important factor that emerged from our data
was GPs’ desire to understand the research
underpinning the eRATs:
‘You wouldn’t really use it without knowing
what or how it was developed, why it was
developed, and what it was for’.
(GP/20)
Some GPs referred to the original research to
question its robustness, for example, they queried
why the eRATs stored data for only one year,
when the original research was based on patients’
records over two years. As aforementioned, par-
ticipants felt that secondary-care practitioners
should be made aware that eRATs were being
used in primary care, and that they were informed
the tools were evidence-based:
‘The biggest challenge [for a general roll-out of
the eRATs] is of course the extra pressure, I
think, on secondary care (…) I think you
would have to liaise with secondary care,
and maybe, there may well be implications for
the workload, particularly for secondary care’.
(GP/15)
Although there were instances when GPs found
the eRATs to be at odds with referral guidelines
from their administrative and commissioning
bodies or with existing local referral guidelines,
overall, respondents felt that the tools com-
plemented the National Institute for Clinical
Excellence cancer referral guidance:
‘Other colleagues have said as well we’re far
more aware of thrombocytosis and increased
platelets. We weren’t aware that tended
to increase the score for increased cancer risk’.
(GP/10)
‘Particularly for the lung cancer or the risk of
lung cancer patients, I found it useful;
I would say not so much for the bowel ones
because it was based on the symptoms we’d
already thought of as potentially risky’.
(GP/6)
Skill-set workability
Key themes: training how to use the new tools;
eRATs in everyday practice; and factors effec-
tingthe optimal use of the tools.
The vast majority of eRATs users were GPs. In
only two cases did interviewees indicate that a
practice nurse or manager had also used the tools,
and in those instances they only used the third
component of each tool (the PPV calculator, which
brings up a list of all patients with a risk of either
lung or colorectal cancer). Few of our respondents,
however, used the calculated PPV tables in this
proactive way, reasoning that it was not feasible
for large practices to call patients in.
Our data suggest that user acceptability and
usability of the tools would have been enhanced
had the training been more comprehensive,
accessible and appropriate. Different approaches
were used to reach GPs with information and
training: a WebEx (online video developed to
support the training aspects of the pilot); an online
discussion forum; and the possibility to discuss
problems with a GP adviser on the telephone or
via email:
‘It [the WebEx] was really long and drawn
out is the honest answer; I think it was half an
hour or an hour, I can’t remember. Yes, but
actually there was a good eight minute slot
that was brilliant that just explained it all, so I
would be tempted I think from watching that
thing it made a big, eh, it was really useful’.
(GP/6)
However, in many cases, respondents conﬁrmed
that only one GP or only the practice manager had
watched the WebEx and then cascaded the infor-
mation to other eRATs-users in the practice. This
had consequences for the use and understanding
of the tools.
In addition to accurate training, efﬁcient use of
the eRATs depends very much on the accuracy
and the level of Read coding (i.e., a standard clin-
ical terminology system). This, in turn, depends on
the individual GP’s recording behaviour:
‘You have to have a consistent way of
recording Read codes. As far as I know there
is no agreement on how to record Read codes
and the symptoms are not that much recor-
ded, but then there is great variance in the
people who record it’.
(GP/5)
Disparities in Read coding was evident through-
out the data, as some respondents indicated that
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they coded everything, whereas others did not use
Read coding very often. This variability in the use
of Read codes by GPs is a limitation to the useful-
ness of any tool that relies on such coding.
Contextual integration
Key themes: outcomes of using the tools; impact
on consultations; and medico-legal implications.
The most signiﬁcant function of the eRATs,
ﬂagged up by the vast majority of GPs, is that the
tools raised awareness about potential cancer
symptoms and both reminded and alerted GPs to
risks:
‘It’s just electronic highlight, makes you think
even if you immediately dismiss it, at least
that millisecond you’ve thought about it, and
I think that is going to be useful at some
point, but for how many people I don’t
know’.
(GP/20)
Despite the danger of an overload of prompts,
most of our participants perceived a future for
electronic aids for GPs within the changing context
of primary care. Most issues highlighted were
germane to new interventions implemented into
general practice, rather than to this particular
intervention: multi-tasking expected from a GP
within one consultation; constant time pressures;
and the possibility of medico-legal repercussions:
‘There is, I suppose, the challenge of more
and more prompts that, you know, say for us,
your prompt box will get bigger and bigger.
However, work in general practice is getting
bigger and bigger, and more work’s going to
come to general practice. So although it can
cause irritation, the ﬂip side of that is you can
relax a little bit more and that you don’t have
to remember absolutely everything (…) You
know, how to sort the wheat from the chaff.
So although people might think it’s irritating,
it can be reassuring’.
(GP/22)
Interviewees stressed that the key aim of a con-
sultation is to address patients’ ideas, concerns and
expectations. However, during a consultation, on-
screen prompts, usually related to QOF activities,
often appear, which alert the GP to other tasks
they need to complete; this in turn directs their
attention away from the patient:
‘There’s a dichotomy between the very useful
information that’s on the computer, and
actually, you know, sort of, looking at the
patients, and giving them, you know, proper
attention, as they perceive it, you know’.
(GP/15)
Although not speciﬁcally asked about in the
interviews, several respondents expressed concern
with regard to the medico-legal implications of
using eRATs, for example, of not referring a
patient who had been brought to their attention
via a prompt:
‘Quite a few partners were worried about any
medico-legal implications with that. I think
the one criticism was having the list of patient
with PPVs. No one really liked that. That was
worrying. We’re worried about if patients
knew that you had a list of them with the risk
and you hadn’t acted on it, what would be the
implications? That was probably a point that
put people off, really’.
(GP/17)
Several others commented on the contradictory
pressures GPs experience, for example, being
urged to limit referrals for ﬁnancial reasons while
simultaneously being asked to make earlier refer-
rals of potential cancer patients. As our inter-
viewees commented, however, all GPs would want
to refer suspected cancer cases as early as possible.
Discussion and conclusion
Our analysis has demonstrated that developing
and integrating new electronic tools into general
practice is challenging. This ﬁnding is not new and
should, therefore, not be surprising (May, 2006;
May et al., 2007a, 2007b). However, this is the ﬁrst
time that an attempt has been made to incorporate
eRATs for cancer diagnosis into GPs’ electronic
systems. Useful lessons have emerged regarding
cancer diagnosis, engaging with practices and the
usefulness of the eRATs as diagnostic tools. First,
GPs reported learning about new aspects of cancer
symptom presentation as a result of using the
eRATs, and thus the tools in themselves were
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educational. Second, there are clear challenges to
the dissemination of training in using new elec-
tronic tools and implementing these into routine
practice. Therefore, eRATs and other clinical
decision-support tools need to be accompanied
with training and guidance regarding their use.
Although training tools can be distributed to
practices, ensuring that practitioners access, use
and understand them is challenging; thus, wider
dissemination of the eRATs would necessitate
adequate resources and follow-up support (Green
et al., 2014). Third, there was a lot of criticism
about the glitches present in the eRATs at the time
of our interviews; therefore, further development
of these tools is required to make them ﬁt for
purpose.
The main limitation of this study is that it is
probable that the GPs who took part in this eva-
luation were ‘keen’ and/or interested in cancer
diagnosis, as the aforementioned GPs we inter-
viewed were self-selecting. However, we did not
end up exclusively with enthusiasts, which is reas-
suring in terms of trying to access and present a
range of opinions.
This evaluation was preceded by an evaluation
of the desk-based RATs (Hamilton et al., 2013;
Green et al., 2014) and has reiterated several of the
ﬁndings from that study, but has given new insights
into the challenges and opportunities of transfer-
ring desk- or paper-based guidance to an electro-
nic system – even at a time when electronic tools
are the common currency of society. In their sys-
tematic review, Mansell et al. (2011) found limited
evidence to suggest that complex interventions
have addressed primary-care aspects of cancer
recognition and referral to date, but concluded
that those that offer improvements to practi-
tioners’ knowledge of cancer symptoms might lead
to changes in behaviour, which in turn impacts
attitudes and decision‐making. Appropriately
supported dissemination of clinical decision-
support tools for cancer may well have a role in
this endeavour.
In summary, the NPM facilitated our analysis as
to how eRATs were adopted by some users while
others were less enthusiastic. Many respondents
conﬁrmed that cancer was brought more to the
forefront of their minds and that the eRATs, coined
by users as ‘alerting mechanisms’ and ‘reminder
tools’, were stimuli for discussion among GPs.
Although we have identiﬁed albeit a limited
workability, the eRATs have not been embedded,
and thus not been ‘normalised’ as complex inter-
ventions into everyday practice.
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